Marisa H. Miceli
Expertise in
11
conditions

Dr. Marisa H. Miceli

Infectious Disease
1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
Accepting New Patients
Offers Telehealth
Expertise in
11
conditions
1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 

Overview

Additional training:Residency: Internal Medicine, Hospital Zonal de Agudos General Manuel Belgrano, Villa Zagala, Buenos Aires, Argentina, 1996Fellowship: Infectious Diseases, Centro de Educación Médica e Investigaciones Clínicas (CEMIC), Buenos Aires, Argentina, 2000 Infectious Diseases Transplant, Foundation for the fight against leukemia (Fundaleu), Buenos Aires, Argentina, 2002.

Dr. Miceli is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Blastomycosis, Pneumocystis Jiroveci Pneumonia, Cytomegalovirus Infection, and Cytomegalic Inclusion Disease.

Dr. Miceli is board certified in Infectious Disease. She is actively involved in clinical research, co-authoring 60 peer reviewed articles and participating in 2 clinical trials. Dr. Miceli is currently accepting new patients.

Specialties

Infectious Disease

Licenses

Internal Medicine in MI

Board Certifications

Infectious Disease

Fellowships

Henry Ford Health System, Infectious Disease & Transplant, 2013
University of New Mexico, Internal Medicine Infectious Disease, 2009

Hospital Affiliations

University Of Michigan Health System

Languages Spoken

English
Spanish

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Health Alliance Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Taubman Center
1500 E Medical Center Dr, Floor 3 Reception D, Ann Arbor, MI 48109

Additional Areas of Focus

Dr. Miceli has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Cellulitis
Measles
Endocarditis
Osteomyelitis
COVID-19

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)
Open-Label Study to Evaluate the Efficacy and Safety of SCY-078 (Ibrexafungerp) in Patients With Fungal Diseases That Are Refractory to or Intolerant of Standard Antifungal Treatment (FURI)
Enrollment Status: Completed
Publish Date: November 20, 2024
Intervention Type: Drug
Study Drug: Ibrexafungerp
Study Phase: Phase 3
SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative Trial
SUBA-itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses: a Multi-center, Open-label Comparative Trial
Enrollment Status: Completed
Publish Date: July 07, 2023
Intervention Type: Drug
Study Drug: SUBA itraconazole
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

60 Total Publications

Off the Map: A Ten-Year Review of Coccidioidomycosis in Southeastern Michigan.
Off the Map: A Ten-Year Review of Coccidioidomycosis in Southeastern Michigan.
Journal: Journal of fungi (Basel, Switzerland)
Published: May 03, 2026
Similar Doctors
Expertise in
16
conditions
Dr. Tejal N. Gandhi
Infectious Disease
Expertise in
16
conditions
Dr. Tejal N. Gandhi
Infectious Disease
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (0.1 miles away)
734-647-5899
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Tejal Gandhi is an Infectious Disease provider practicing medicine in Ann Arbor, Michigan. Dr. Gandhi is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, Chronic Recurrent Multifocal Osteomyelitis, and Osteomyelitis. Dr. Gandhi is board certified in Infectious Disease. Dr. Gandhi is currently accepting new patients.

Expertise in
15
conditions
Dr. Lindsay A. Petty
Infectious Disease | Pediatrics
Expertise in
15
conditions
Dr. Lindsay A. Petty
Infectious Disease | Pediatrics
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (0.1 miles away)
734-647-5899
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lindsay Petty is an Infectious Disease specialist and a Pediatrics provider practicing medicine in Ann Arbor, Michigan. Dr. Petty is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Asymptomatic Bacteriuria, Pneumonia, COVID-19, and Febrile Neutropenia. Dr. Petty is board certified in Infectious Disease. Dr. Petty is currently accepting new patients.

Expertise in
23
conditions
Dr. Daniel R. Kaul
Infectious Disease
Expertise in
23
conditions
Dr. Daniel R. Kaul
Infectious Disease
Referral may be required

Taubman Center

1500 E Medical Center Dr, Floor 3 Reception D, 
Ann Arbor, MI 
 (0.1 miles away)
734-647-5899
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Kaul is an Infectious Disease provider practicing medicine in Ann Arbor, Michigan. Dr. Kaul is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Cytomegalic Inclusion Disease, Cytomegalovirus Infection, HIV/AIDS, and Myelitis. Dr. Kaul is board certified in Infectious Disease. Dr. Kaul is currently accepting new patients.

Frequently Asked Questions about Dr. Marisa H. Miceli

How do I make an appointment with Dr. Marisa H. Miceli?

You can book an appointment with Dr. Marisa H. Miceli by calling their office at 734-647-5899. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Marisa H. Miceli a top-rated expert for Blastomycosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Marisa H. Miceli is classified as an Distinguished expert for Blastomycosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Marisa H. Miceli specialize in?

While Dr. Marisa H. Miceli is a Infectious Disease, they have specific expertise in Blastomycosis, Pneumocystis Jiroveci Pneumonia, and Cytomegalovirus Infection. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.

Does Dr. Marisa H. Miceli participate in research or clinical trials?

Yes. Dr. Marisa H. Miceli has published 60 articles and abstracts on conditions like Blastomycosis. You can view a list of Dr. Marisa H. Miceli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Marisa H. Miceli accept my insurance?

Dr. Marisa H. Miceli accepts most major insurance plans, including Aetna and Blue Cross Blue Shield. We recommend calling the office directly at 734-647-5899 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miceli's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 32 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile